谷歌浏览器插件
订阅小程序
在清言上使用

Nivolumab and Sunitinib in Patients with Advanced Bone Sarcomas: A Multicenter, Single-Arm, Phase 2 Trial.

CANCER(2025)

引用 0|浏览2
关键词
anti-angiogeninic,bone,dedifferentiated chondrosarcoma,Ewing sarcoma,immunotherapy,nivolumab,osteosarcoma,PD-L1 inhibitor,sarcoma,sunitinib
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要